-
May 10, 2022 Why Wednesday Will Be Biggest Day of 2022 for Psychedelic InvestorsPsychedelic investors are about to see pivotal data presented on flagship programs by the titans...
-
May 9, 2022 Five Telling Takeways from Benzinga Psychedelics Capital ConferencePsychedelic Spotlight's video producer attended the inaugural Benzinga Psychedelic Capital Conference, and here's what he...
-
May 6, 2022 Psychedelic Business Spotlight – May 6This week in psychedelic business news: Wesana Health pivots strategy; Compass Pathways makes progress on...
-
May 6, 2022 Wesana Health May Sell Clinics to Focus Solely on Drug Development: An AnalysisWesana Health reaches a major strategic pivot point. Our resident Psychedelic Investor examines what this...
-
May 5, 2022 Compass Pathways Shares ‘Promising’ Data That Psilocybin May Treat AnorexiaThere is currently no FDA-approved treatment for anorexia. Could psychedelics be the answer?
-
May 4, 2022 Fungus Among Us: 5 Fascinating Facts About MushroomsScience just keeps discovering how cool and beneficial mushrooms are, with or without psilocybin.
-
May 2, 2022 Elon Musk Excites Psychedelic Industry CEOs with This TweetThis is one of the billionaire's most explicit acknowledgments of the power of psychedelics for...
-
April 29, 2022 Why Field Trip Health Is Dividing in Two — and What This Means for InvestorsField Trip Health plans to split into two independent, publicly traded companies: Field Trip Health...
-
April 29, 2022 Psychedelic Business Spotlight – April 29This week in psychedelic business news: Field Trip Health splits in two, Tryp Therapeutics commences...
-
April 28, 2022 MAPS Navigates Multiple Scandals: Why Health Canada Is Reviewing MDMA TrialsA sexual misconduct scandal, a data scandal, and an elder abuse scandal haunt psychedelics leader...
